Page last updated: 2024-11-04

temozolomide and Hives

temozolomide has been researched along with Hives in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Temozolomide is an oral alkylating agent approved for the treatment of glioblastoma and anaplastic astrocytoma, and is currently under clinical investigation for the treatment of brain metastases from a variety of cancers."7.76Urticarial hypersensitivity reaction caused by temozolomide. ( Hsu, MY; Ibrahimi, OA; Kesari, S; Pothiawala, S; Yang, C, 2010)
"Temozolomide is an oral alkylating agent approved for the treatment of glioblastoma and anaplastic astrocytoma, and is currently under clinical investigation for the treatment of brain metastases from a variety of cancers."3.76Urticarial hypersensitivity reaction caused by temozolomide. ( Hsu, MY; Ibrahimi, OA; Kesari, S; Pothiawala, S; Yang, C, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pothiawala, S1
Hsu, MY1
Yang, C1
Kesari, S1
Ibrahimi, OA1

Other Studies

1 other study available for temozolomide and Hives

ArticleYear
Urticarial hypersensitivity reaction caused by temozolomide.
    Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:9

    Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Da

2010